Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03711734 · ClinicalTrials.gov registry record · NA

Acupuncture ACL (Anterior Cruciate Ligament)

A NA study of Anesthesia and ACL Injury, sponsored by Hospital for Special Surgery, New York.

Completed
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT03711734 is a NA study of Anesthesia and ACL Injury that has completed, run by Hospital for Special Surgery, New York. The registered enrollment target is 40 participants, below the 109,410-participant average among 57 other Anesthesia trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03711734, a NA study of Anesthesia and ACL Injury, has completed, sponsored by Hospital for Special Surgery, New York.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

Acupuncture research in regards to PONV has been fairly well established, however, studies about perioperative pain control and acupuncture are a little more murky. In 2008, a meta analysis looked at randomized controlled studies and found that while acupuncture was shown to decrease pain, there were limitations including credible placebo or sham intervention, and thus, blinding. The main purpose of this feasibility trial is to determine whether or not adequate blinding is possible in the intraoperative setting with the patient sedated.

Interventions

  • OTHER Acupuncture + Standard of Care

Study Locations (1)

New York

  • Hospital for Special Surgery - New York

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2018-11-01
Est. Completion 2019-12-13
Phase NA

What the Registry Record Tells You About NCT03711734

The ClinicalTrials.gov registry entry for NCT03711734 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 109,410-participant average among 57 other Anesthesia trials with a reported enrollment target (100% lower). The listed sponsor is Hospital for Special Surgery, New York, which has 194 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Anesthesia appearing as the primary indexed condition, and to 1 intervention - of which Acupuncture + Standard of Care is the first listed.

NCT03711734 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT03711734 about?

NCT03711734 is a clinical study titled "Acupuncture ACL (Anterior Cruciate Ligament)". Acupuncture research in regards to PONV has been fairly well established, however, studies about perioperative pain control and acupuncture are a little more murky. In 2008, a meta analysis looked at randomized controlled studies and found that while acupuncture was shown to decrease pain, there wer...

What is the current status of trial NCT03711734?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2018-11-01. Estimated completion is 2019-12-13.

What conditions does trial NCT03711734 study?

This clinical trial studies the following conditions: Anesthesia, ACL Injury, Anterior Cruciate Ligament Rupture, Anterior Cruciate Ligament Injury, ACL.

What interventions are being tested in trial NCT03711734?

The interventions under investigation include: Acupuncture + Standard of Care (OTHER).

Who is sponsoring clinical trial NCT03711734?

This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03711734 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anesthesia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.